Tau and caspase 3 as targets for neuroprotection

International Journal of Alzheimer's Disease

Volumn , Issue , 2012, Pages

  Idan Feldman, Anat ^a   Ostritsky, Regina ^a   Gozes, Illana ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; DAVUNETIDE; GLUCOSE; OXYGEN; TAU PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; IMMUNOBLOTTING; ISCHEMIA; MITOCHONDRION; NERVE CELL CULTURE; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RAT;

EID: 84862270024     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.1155/2012/493670     Document Type: Article

References (64)

1. Bassan M., Zamostiano R., Davidson A., Pinhasov A., Giladi E., Perl O., Bassan H., Blat C., Gibney G., Glazner G., Brenneman D. E., Gozes I., Complete sequence of a novel protein containing a femtomolar-activity- dependent neuroprotective peptide Journal of Neurochemistry 1999 72 3 1283 1293 (Pubitemid 29085045)
2. Gozes I., Morimoto B. H., Tiong J., Fox A., Sutherland K., Dangoor D., Holser-Cochav M., Vered K., Newton P., Aisen P. S., Matsuoka Y., Van Dyck C. H., Thal L., NAP: research and development of a peptide derived from activity-dependent neuroprotective protein (ADNP) CNS Drug Reviews 2005 11 4 353 368
3. Shiryaev N., Pikman R., Giladi E., Gozes I., Protection against tauopathy by the drug candidates NAP (Davunetide) and D-SAL: biochemical, cellular and behavioral aspects Current Pharmaceutical Design 2011 17 25 2603 2612
4. Vulih-Shultzman I., Pinhasov A., Mandel S., Grigoriadis N., Touloumi O., Pittel Z., Gozes I., Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model Journal of Pharmacology and Experimental Therapeutics 2007 323 2 438 449 (Pubitemid 350005131)
5. Shiryaev N., Jouroukhin Y., Giladi E., Polyzoidou E., Grigoriadis N. C., Rosenmann H., Gozes I., NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model Neurobiology of Disease 2009 34 2 381 388
6. Leker R. R., Teichner A., Grigoriadis N., Ovadia H., Brenneman D. E., Fridkin M., Giladi E., Romano J., Gozes I., NAP, a femtomolar-acting peptide, protects the brain against ischemic injury by reducing apoptotic death Stroke 2002 33 4 1085 1092 (Pubitemid 34293596)
7. Idan-Feldman A, Schirer Y., Polyzoidou E., Touloumi O., Lagoudaki R., Grigoriadis N. C., Gozes I., Davunetide (NAP) as a preventative treatment for central nervous system complications in a diabetes rat model Neurobiology of Disease 2011 44 3 327 339
8. Grundke-Iqbal I., Iqbal K., Tung Y. C., Abnormal phosphorylation of the microtubule-associated protein (tau) in Alzheimer cytoskeletal pathology Proceedings of the National Academy of Sciences of the United States of America 1986 83 13 44913 4917
9. Lee V. M. Y., Goedert M., Trojanowski J. Q., Neurodegenerative tauopathies Annual Review of Neuroscience 2001 24 1121 1159 (Pubitemid 32695256)
10. Iqbal K., Grundke-Iqbal I., Zaidi T., Defective brain microtubule assembly in Alzheimer's disease The Lancet 1986 2 8504 421 426 (Pubitemid 16047953)
11. Ebneth A., Godemann R., Stamer K., Illenberger S., Trinczek B., Mandelkow E. M., Mandelkow E., Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease Journal of Cell Biology 1998 143 3 777 794 (Pubitemid 28512571)
12. Terwel D., Dewachter I., Van Leuven F., Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease NeuroMolecular Medicine 2002 2 2 151 165 (Pubitemid 37012502)
13. Drechsel D. N., Hyman A. A., Cobb M. H., Kirschner M. W., Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau Molecular Biology of the Cell 1992 3 10 1141 1154 (Pubitemid 23088964)
14. Bramblett G. T., Goedert M., Jakes R., Merrick S. E., Trojanowski J. Q., Lee-V. M. Y., Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding Neuron 1993 10 6 1089 1099 (Pubitemid 23194399)
15. Biernat J., Gustke N., Drewes G., Mandelkow E. M., Mandelkow E., Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding Neuron 1993 11 1 153 163 (Pubitemid 23222542)
16. Alonso A. D. C., Zaidi T., Novak M., Grundke-Iqbal I., Iqbal K., Hyperphosphorylation induces self-assembly of into tangles of paired helical filaments/straight filaments Proceedings of the National Academy of Sciences of the United States of America 2001 98 12 6923 6928 (Pubitemid 32538318)
17. Alonso A. D. C., Zaidi T., Grundke-Iqbal I., Iqbal K., Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease Proceedings of the National Academy of Sciences of the United States of America 1994 91 12 5562 5566 (Pubitemid 24174368)
18. Alonso Alejandra del C., Grundke-Iqbal I., Iqbal K., Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules Nature Medicine 1996 2 7 783 787 (Pubitemid 26225094)
19. Goedert M., Spillantini M. G., Pathogenesis of the Tauopathies Journal of Molecular Neuroscience 2011 45 425 431
20. Guillozet A. L., Weintraub S., Mash D. C., Marsel Mesulam M., Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment Archives of Neurology 2003 60 5 729 736 (Pubitemid 36569891)
21. Arriagada P. V., Growdon J. H., Hedley-Whyte E. T., Hyman B. T., Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease Neurology 1992 42 3 I 631 639
22. Braak H., Braak E., Evolution of the neuropathology of Alzheimer's disease Acta Neurologica Scandinavica 1996 93 165 3 12 (Pubitemid 26143161)
23. Lassmann H., Bancher C., Breitschopf H., Wegiel J., Bobinski M., Jellinger K., Wisniewski H. M., Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ Acta Neuropathologica 1995 89 1 35 41
24. Bancher C., Lassmann H., Budka H., Neurofibrillary tangles in Alzheimer's disease and progressive supranuclear palsy: antigenic similarities and differences. Microtubule-associated protein tau antigenicity is prominent in all types of tangles Acta Neuropathologica 1987 74 1 39 46 (Pubitemid 17105416)
25. Goedert M., Clavaguera F., Tolnay M., The propagation of prion-like protein inclusions in neurodegenerative diseases Trends in Neurosciences 2010 33 7 317 325
26. Liu L., Drouet V., Wu J. W., Witter M.P., Small S.A., Clelland C., Duff K., Trans-synaptic spread of tau pathology in vivo PLoS ONE 2012 7 2
27. Santacruz K., Lewis J., Spires T., Paulson J., Kotilinek L., Ingelsson M., Guimaraes A., DeTure M., Ramsden M., McCowan E., Forster C., Yue M., Orne J., Janus C., Mariash A., Kuskowski M., Hyman B., Hutton M., Ashe K. H., Medicine: tau suppression in a neurodegenerative mouse model improves memory function Science 2005 309 5733 476 481 (Pubitemid 40994688)
28. Oddo S., Vasilevko V., Caccamo A., Kitazawa M., Cribbs D. H., LaFerla F. M., Reduction of soluble A and tau, but not soluble A alone, ameliorates cognitive decline in transgenic mice with plaques and tangles Journal of Biological Chemistry 2006 281 51 39413 39423 (Pubitemid 46041901)
29. Berger Z., Roder H., Hanna A., Carlson A., Rangachari V., Yue M., Wszolek Z., Ashe K., Knight J., Dickson D., Andorfer C., Rosenberry T. L., Lewis J., Hutton M., Janus C., Accumulation of pathological tau species and memory loss in a conditional model of tauopathy Journal of Neuroscience 2007 27 14 3650 3662 (Pubitemid 46557687)
30. Cotman C. W., Poon W. W., Rissman R. A., Blurton-Jones M., The role of caspase cleavage of tau in Alzheimer disease neuropathology Journal of Neuropathology and Experimental Neurology 2005 64 2 104 112 (Pubitemid 40349308)
31. Gamblin T. C., Chen F., Zambrano A., Abraha A., Lagalwar S., Guillozet A. L., Lu M., Fu Y., Garcia-Sierra F., LaPointe N., Miller R., Berry R. W., Binder L. I., Cryns V. L., Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease Proceedings of the National Academy of Sciences of the United States of America 2003 100 17 10032 10037 (Pubitemid 37087063)
32. Rissman R. A., Poon W. W., Blurton-Jones M., Oddo S., Torp R., Vitek M. P., LaFerla F. M., Rohn T. T., Cotman C. W., Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology Journal of Clinical Investigation 2004 114 1 121 130 (Pubitemid 39071651)
33. De Calignon A., Fox L. M., Pitstick R., Carlson G. A., Bacskai B. J., Spires-Jones T. L., Hyman B. T., Caspase activation precedes and leads to tangles Nature 2010 464 7292 1201 1204
34. Chung C.-W., Song Y.-H., Kim I.-K., Yoon W.-J., Ryu B.-R., Jo D.-G., Woo H.-N., Kwon Y.-K., Kim H.-H., Gwag B.-J., Mook-Jung I.-H., Jung Y.-K., Proapoptotic effects of Tau cleavage product generated by caspase-3 Neurobiology of Disease 2001 8 1 162 172 (Pubitemid 32171828)
35. Guise S., Braguer D., Carles G., Delacourte A., Briand C., Hyperphosphorylation of tau is mediated by erk activation during anticancer drug-induced apoptosis in neuroblastoma cells Journal of Neuroscience Research 2001 63 3 257 267 (Pubitemid 32115287)
36. Rametti A., Esclaire F., Yardin C., Terro F., Linking alterations in tau phosphorylation and cleavage during neuronal apoptosis Journal of Biological Chemistry 2004 279 52 54518 54528 (Pubitemid 40053193)
37. Rohn T. T., Head E., Caspases as therapeutic targets in Alzheimer's disease: is it time to Cut" to the chase? International Journal of Clinical and Experimental Pathology 2009 2 2 108 118
38. Rohn T. T., Kokoulina P., Eaton C. R., Poon W. W., Caspase activation in transgenic mice with Alzheimer-like pathology: results from a pilot study utilizing the caspase inhibitor, Q-VD-OPh International Journal of Clinical and Experimental Medicine 2009 2 4 300 308
39. Zemlyak I., Sapolsky R., Gozes I., NAP protects against cytochrome c release: inhibition of the initiation of apoptosis European Journal of Pharmacology 2009 618 1-3 9 14
40. Zhang Z. H., Fang X. B., Xi G. M., Li W. C., Ling H. Y., Qu P., Calcitonin gene-related peptide enhances CREB phosphorylation and attenuates tau protein phosphorylation in rat brain during focal cerebral ischemia/reperfusion Biomedicine and Pharmacotherapy 2010 64 6 430 436
41. Wang H., Zhao H., Ye Y., Xiong N., Huang J., Yao D., Shen Y., Zhao X., Focal cerebral ischemia induces Alzheimer's disease-like pathological change in rats Journal of Huazhong University of Science and Technology 2010 30 1 29 36
42. Zhang Z. H., Xi G. M., Li W. C., Ling H. Y., Qu P., Fang X. B., Cyclic-AMP response element binding protein and tau are involved in the neuroprotective mechanisms of nerve growth factor during focal cerebral ischemia/reperfusion in rats Journal of Clinical Neuroscience 2010 17 3 353 356
43. Chauvier D., Ankri S., Charriaut-Marlangue C., Casimir R., Jacotot E., Broad-spectrum caspase inhibitors: from myth to reality? Cell Death and Differentiation 2007 14 2 387 391 (Pubitemid 46092244)
44. Mandel S., Gozes I., Activity-dependent neuroprotective protein constitutes a novel element in the SWI/SNF chromatin remodeling complex Journal of Biological Chemistry 2007 282 47 34448 34456 (Pubitemid 350159432)
45. Matsuoka Y., Gray A. J., Hirata-Fukae C., Minami S. S., Waterhouse E. G., Mattson M. P., LaFerla F. M., Gozes I., Aisen P. S., Intranasal NAP administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of Alzheimer's disease at early pathological stage Journal of Molecular Neuroscience 2007 31 2 165 170 (Pubitemid 46742300)
46. Matsuoka Y., Jouroukhin Y., Gray A. J., Ma L., Hirata-Fukae C., Li H. F., Feng L., Lecanu L., Walker B. R., Planel E., Arancio O., Gozes I., Aisen P. S., A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer's disease Journal of Pharmacology and Experimental Therapeutics 2008 325 1 146 153 (Pubitemid 351439178)
47. Gozes I., Divinski I., The femtomolar-acting NAP interacts with microtubules: novel aspects of astrocyte protection Journal of Alzheimer's Disease 2004 6 S37 S41
48. Sokolowska P., Passemard S., Mok A., Schwendimann L., Gozes I., Gressens P., Neuroprotective effects of NAP against excitotoxic brain damage in the newborn mice: implications for cerebral palsy Neuroscience 2011 173 156 168
49. Zemlyak I., Manley N., Vulih-Shultzman I., Cutler A. B., Graber K., Sapolsky R. M., Gozes I., The microtubule interacting drug candidate NAP protects against kainic acid toxicity in a rat model of epilepsy Journal of Neurochemistry 2009 111 5 1252 1263
50. Gozes I., Steingart R. A., Spier A. D., NAP mechanisms of neuroprotection Journal of Molecular Neuroscience 2004 24 1 67 72 (Pubitemid 41359169)
51. Sari Y., Activity-dependent neuroprotective protein-derived peptide, NAP, preventing alcohol-induced apoptosis in fetal brain of C57BL/6 mouse Neuroscience 2009 158 4 1426 1435
52. Zemlyak I., Manley N., Sapolsky R., Gozes L., NAP protects hippocampal neurons against multiple toxins Peptides 2007 28 10 2004 2008 (Pubitemid 47419114)
53. Pascual M., Guerri C., The peptide NAP promotes neuronal growth and differentiation through extracellular signal-regulated protein kinase and Akt pathways, and protects neurons co-cultured with astrocytes damaged by ethanol Journal of Neurochemistry 2007 103 2 557 568 (Pubitemid 47498015)
54. Dugan L. L., Bruno V. M. G., Amagasu S. M., Giffard R. G., Glia modulate the response of murine cortical neurons to excitotoxicity: glia exacerbate AMPA neurotoxicity Journal of Neuroscience 1995 15 6 4545 4555
55. Zemlyak I., Furman S., Brenneman D. E., Gozes I., A Novel peptide prevents death in enriched neuronal cultures Regulatory Peptides 2000 96 1-2 39 43
56. Zaltzman R., Alexandrovich A., Beni S. M., Trembovler V., Shohami E., Gozes I., Brain injury-dependent expression of activity-dependent neuroprotective protein Journal of Molecular Neuroscience 2004 24 2 181 187 (Pubitemid 41359145)
57. Fernandez-Montesinos R., Torres M., Baglietto-Vargas D., Gutierrez A., Gozes I., Vitorica J., Pozo D., Activity-dependent neuroprotective protein (ADNP) expression in the amyloid precursor protein/presenilin 1 mouse model of Alzheimer's disease Journal of Molecular Neuroscience 2010 41 1 114 120
58. Gozes I., Zaltzman R., Hauser J., Brenneman D. E., Shohami E., Hill J. M., The expression of activity-dependent neuroprotective protein (ADNP) is regulated by brain damage and treatment of mice with the ADNP derived peptide, NAP, reduces the severity of traumatic head injury Current Alzheimer Research 2005 2 2 149 153 (Pubitemid 40862875)
59. Furman S., Steingart R. A., Mandel S., Subcellular localization and secretion of activity-dependent neuroprotective protein in astrocytes Neuron Glia Biology 2004 1 193 199
60. Steingart R. A., Gozes I., Recombinant activity-dependent neuroprotective protein protects cells against oxidative stress Molecular and Cellular Endocrinology 2006 252 1-2 148 153
61. Smith-Swintosky V. L., Gozes I., Brenneman D. E., D'Andrea M. R., Plata-Salaman C. R., Activity-dependent neurotrophic factor-9 and NAP promote neurite outgrowth in rat hippocampal and cortical cultures Journal of Molecular Neuroscience 2005 25 3 225 237 (Pubitemid 41389347)
62. Lagrze W. A., Pielen A., Steingart R., Schlunck G., Hofmann H. D., Gozes I., Kirsch M., The peptides ADNF-9 and NAP increase survival and neurite outgrowth of rat retinal ganglion cells in vitro Investigative Ophthalmology and Visual Science 2005 46 3 933 938 (Pubitemid 41321030)
63. Gozes I., Divinski I., NAP, a neuroprotective drug candidate in clinical trials, stimulates microtubule assembly in the living cell Current Alzheimer Research 2007 4 5 507 509 (Pubitemid 350248382)
64. Divinski I., Mittelman L., Gozes I., A femtomolar acting octapeptide interacts with tubulin and protects astrocytes against zinc intoxication Journal of Biological Chemistry 2004 279 27 28531 28538 (Pubitemid 38900136)